A truncated HMGA1 gene induces proliferation of the 3T3-L1 pre-adipocytic cells: A model of human lipomas

Carcinogenesis

Volumn 24, Issue 12, 2003, Pages 1861-1869

  Pierantoni, Giovanna Maria ^a   Battista, Sabrina ^a   Pentimalli, Francesca ^a   Fedele, Monica ^a   Visone, Rosa ^a   Federico, Antonella ^a   Santoro, Massimo ^a   Viglietto, Giuseppe ^a   Fusco, Alfredo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME PROTEIN; HIGH MOBILITY GROUP A PROTEIN; HIGH MOBILITY GROUP A1 PROTEIN; HIGH MOBILITY GROUP A2 PROTEIN; NONHISTONE PROTEIN; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BENIGN TUMOR; CARCINOGENESIS; CELL COUNT; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN 3T3; CHROMATIN STRUCTURE; CHROMOSOME TRANSLOCATION; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; FREQUENCY ANALYSIS; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE INDUCTION; GENE REARRANGEMENT; GROWTH RATE; LIPOMA; MALIGNANT NEOPLASTIC DISEASE; MESENCHYMOMA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROADIPOCYTE; PROMOTER REGION; PROTEIN ASSEMBLY; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; REGULATORY MECHANISM; T LYMPHOCYTE; TUMOR MODEL; WILD TYPE;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CHROMOSOMES; FLOW CYTOMETRY; G0 PHASE; G1 PHASE; GENETIC VECTORS; HMGA1A PROTEIN; IMMUNOBLOTTING; LIPOMA; MICE; MICROSCOPY, PHASE-CONTRAST; MODELS, GENETIC; PHENOTYPE; PLASMIDS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TRANSFECTION;

EID: 0348149141     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgg149     Document Type: Article

References (51)

1. Johnson,K.R., Lehn,D.A. and Reeves,R. (1989) Alternative processing of mRNA's coding for human HMG I and HMG Y proteins. Mol. Cell. Biol., 9, 2114-2123.
2. Manfioletti,G., Giancotti,V., Bandiera,A., Buratti,E., Sautiere,P., Cary,P., Crane-Robinson,C., Coles,B. and Goodwin,G.H. (1991) cDNA cloning of the HMGI-c phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes. Nucleic Acids Res., 19, 6793-6797.
3. Wolffe,A.P. (1994) Architectural transcription factors. Science, 264, 1100-1101.
4. Thanos,D. and Maniatis,T. (1992) The high mobility group protein HMG I (Y) is required for NF-κB dependent virus induction of the human IFN-β gene. Cell, 71, 777-789.
5. Chuvpilo,S., Schoenberg,C., Gerwig,R., Heinfling,A., Reeves,R., Grummt,F. and Serfling,E. (1993) Multiple closely-linked NFAT/octamer and HMGI (Y) binding sites are part of the interleukin-4 promoter. Nucleic Acids Res., 21, 5694-5704.
6. Du,W., Thanos,D. and Maniatis,T. (1993) Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell, 74, 887-898.
7. Lewis,H., Kaszubska,W., De Lamarter,J.F. and Whelan,J. (1994) Cooperativity between two NF-kappa B complexes, mediated by high-mobility-group protein I (Y), is essential for cytokine-induced expression of the E-selectin promoter. Mol. Cell. Biol., 14, 5701-5709.
8. Zhou,X., Benson,K.F., Ashar,H.R. and Chada,K. (1995) Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature, 376, 771-774.
9. Chiappetta,G., Avantaggiato,V., Visconti,R. et al. (1996) High level expression of the HMGI (Y) gene during embryonic development. Oncogene, 13, 2439-2446.
10. Giancotti,V., Pani,B., D'Andrea,P. et al. (1987) Elevated levels of a specific class of nuclear phosphoroproteins in cells transformed with ras and v-mos oncogenes and by co-transfection with c-myc and Polyoma Middle T genes. EMBO J., 6, 1981-1987.
11. Giancotti,V., Buratti,E., Perissin,L., Zorzet,S., Balmain,A., Portella,G., Fusco,A. and Goodwin,G.H. (1989) Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. Exp. Cell Res., 184, 538-545.
12. Bussemakers,M.J.G., Van de Ven,W.J.M., Debruyne,F.M.J. and Schalken,J. (1991) Identification of high mobility group protein I (Y) as potential progression marker for prostate cancer by differential hybridization analysis. Cancer Res., 51, 606-611.
13. Ram,T.G., Reeves,R. and Hosick,H.L. (1993) Elevated high mobility group I (Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells. Cancer Res., 53, 2655-2660.
14. Tamimi,Y., Van Der Poel,H.G., Denyn,M.M., Umbas,R., Karthaus, H.F.M., Debruyne,F.M.J. and Shalken,J.A. (1993) Increased expression of high mobility group protein I (Y) in high grade prostate cancer determined by in situ hybridization. Cancer Res., 53, 5512-5516.
15. Chiappetta,G., Bandiera,A., Berlingieri,M.T., Visconti,R., Manfioletti,G., Battista,S., Martinez-Tello,F.J., Santoro,M., Giancotti,V. and Fusco,A. (1995) The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasms. Oncogene, 10, 1307-1314.
16. Fedele,M., Bandiera,A., Chiappetta,G. et al. (1996) High mobility group protein I (Y) as potential tumour marker in human colorectal carcinomas. Cancer Res., 56, 1896-1901.
17. Bandiera,A., Bonifacio,D., Manfioletti,G., Mantovani,F., Rustighi,A., Zanconati,F., Fusco,A., Di Bonito,L. and Giancotti,V. (1998) Expression of high mobility group I (HMGI) proteins in squamous intraepithelial lesions (SILs) of uterine cervix. Cancer Res., 58, 426-431.
18. Chiappetta,G., Tallini,G., De Biasio,M.C. et al. (1998) Detection of High Mobility Group I HMGI (Y) proteins in the diagnosis of thyroid tumors: HMGI (Y) expression represents a potential diagnostic indicator of carcinoma. Cancer Res., 58, 4193-4198.
19. Abe,N., Watanabe,T., Sugiyama,M., Uchimura,H., Chiappetta,G., Fusco,A. and Atomi,Y. (1999) Determination of high mobility group I (Y) expression level in colorectal neoplasias: a potential diagnostic marker. Cancer Res., 59, 1169-1174.
20. Abe,N., Watanabe,T., Masaki,T., Mori,T., Sugiyama,M., Uchimura,H., Fujioka,Y., Chiappetta,G., Fusco,A. and Atomi,Y. (2000) Pancreatic duct cell carcinomas express high levels of high mobility group I (Y) proteins. Cancer Res., 60, 3117-3122.
21. Chiappetta,G., Manfioletti,G., Pentimalli,F. et al. (2001) High mobility group HMGI (Y) protein expression in human colorectal hyperplastic and neoplastic diseases. Int. J. Cancer, 91, 147-151.
22. Berlingieri,M.T., Manfioletti,G., Santoro,M., Bandiera,A., Visconti,R., Giancotti,V. and Fusco,A. (1995) Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol. Cell. Biol., 15, 1545-1553.
23. Berlingieri,M.T., Pierantoni,G.M., Giancotti,V., Santoro,M. and Fusco,A. (2002) Thyroid cell transformation requires the expression of the HMGA1 proteins. Oncogene, 21, 2971-2980.
24. Scala,S., Portella,G., Fedele,M., Chiappetta,G. and Fusco,A. (2000) Adenovirus-mediated suppression of HMGI (Y) protein synthesis as potential therapy of human malignant neoplasias. Proc. Natl Acad. Sci. USA, 97, 4256-4261.
25. Ashar,H.R., Schoenberg Fejzo,M., Tkachenko,A., Zhou,X., Fletcher,J.A., Weremowicz,S., Morton,C.C. and Chada,K. (1995) Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell, 82, 57-65.
26. Schoenmakers,E., Wanschura,S., Mols,R., Bullerdiek,J., Van den Berghe,H. and Van de Ven,W.J.M. (1995) Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nature Genet., 10, 436-443.
27. Tkachenko,A., Ashar,H.R., Meloni,A.M., Sandberg,A.A. and Chada,K.K. (1997) Misexpression of disrupted HMGI architectural factors activates alternative pathways of tumorigenesis. Cancer Res., 57, 2276-2280.
28. Xiao,S., Lux,M.L., Reeves,R., Hudson,T.J. and Fletcher,J.A. (1997) HMGI (Y) activation by chromosome 6p21 rearrangements in multi-lineage mesenchymal cells from pulmonary hamartoma. Am. J. Pathol., 150, 901-910.
29. Fedele,M., Battista,S., Manfioletti,G., Croce,C.M., Giancotti,V. and Fusco,A. (2001) Role of the high mobility group A proteins in human lipomas. Carcinogenesis, 22, 1583-1591.
30. Fedele,M., Berlingieri,M.T., Scala,S., Chiariotti,L., Viglietto,G., Rippel,V., Bullerdiek,J., Santoro,M. and Fusco,A. (1998) Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts. Oncogene, 17, 413-418.
31. Battista,S., Fidanza,V., Fedele,M., Klein-Szanto,A.J., Outwater,E., Brunner,H., Santoro,M., Croce,C.M. and Fusco,A. (1999) The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. Cancer Res., 59, 4793-4797.
32. Arlotta,P., Tai,A.K., Manfioletti,G., Clifford,C., Jay,G. and Ono,S.J. (2000) Transgenic mice expressing a truncated form of the high mobility group I-C protein develop adiposity and an abnormally high prevalence of lipomas. J. Biol. Chem., 275, 14394-14400.
33. Melillo,R.M., Pierantoni,G.M., Scala,S. et al. (2001) Critical role of the HMGI (Y) proteins in adipocytic cell growth and differentiation. Mol. Cell. Biol., 21, 2485-2495.
34. Student,A.K., Hsu,R.Y. and Lane,M.D. (1980) Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. J. Biol. Chem., 255, 4745-4750.
35. Santoro,M., Carlomagno,F., Romano,A. et al. (1995) Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science, 267, 381-383.
36. Graham,F.L. and Van der Eb,A.J. (1973) A new technique for the assay of the infectivity of human adenovirus 5 DNA. Virology, 52, 456-467.
37. Vallone,D., Battista,S., Pierantoni,G.M., Fedele,M., Casalino,L., Santoro,M., Viglietto,G. Fusco,A. and Verde,P. (1997) Neoplastic transformation of rat thyroid cells requires the JunB and Fra1 gene induction which is dependent on the HMGI-C gene products. EMBO J., 17, 5310-5321.
38. Cook,J.S., Lucas,J.J., Sibley,E., Bolanowski,M.A., Christy,R.J., Kelly,T.J. and Lane,M.D. (1988) Expression of the differentiation-induced gene for fatty acid-binding protein is activated by glucocorticoid and cAMP. Proc. Natl Acad. Sci. USA, 85, 2949-2953.
39. Hwang,C.S., Mandrup,S., MacDougald,O.A., Geiman,D.E. and Lane,M.D. (1996) Transcriptional activation of the mouse obese (ob) gene by CCAAT/enhancer binding protein alpha. Proc. Natl Acad. Sci. USA, 93, 873-877.
40. Kirchgessner,T.G., Svenson,K.L., Lusis,A.J. and Schotz,M.C. (1987) The sequence of cDNA encoding lipoprotein lipase. A member of a lipase gene family. J. Biol. Chem., 262, 8463-8466.
41. Dani,C., Doglio,A., Grimaldi,P. and Ailhaud,G. (1986) Expression of the phosphoenolpyruvate carboxykinase gene and its insulin regulation during differentiation of preadipose cell lines. Biochem. Biophys. Res. Commun., 138, 468-475.
42. Tontonoz,P., Hu,E. and Spiegelman,B.M. (1994) Stimulation of adipogenesis in fibroblasts by PPARγ, a lipid-activated transcription factor. Cell, 79, 1147-1156.
43. Macpherson,I. and Montagnier,I. (1964) Agar suspension culture for the selected assay of cells transformed by polioma virus. Virology, 23, 291-294.
44. Chen,P.L., Riley,D.J., Chen,Y. and Lee,W.H. (1996) Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev., 10, 2794-2804.
45. Krishan,A. (1975) Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell. Biol., 66, 188-193.
46. Friedmann,M., Holth,L.T., Zoghbi,H.Y. and Reeves,R. (1993) Organization, inducible-expression and chromosome localization of the human HMG-I (Y) nonhistone protein gene. Nucleic Acids Res., 21, 4259-4267.
47. Reed,S.I., Bailly,E., Dulic,V., Hengst,L., Resnitzky,D. and Slingerland,J. (1994) G1 control in mammalian cells. J. Cell Sci., 18, 69-73.
48. 1 cyclin-dependent kinases. Genes Dev., 9, 1149-1163.
49. Helin,K., Harlow,E. and Fattaey,A. (1993) Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol., 13. 6501-6508.
50. Nevins,J.R. (1992) E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science, 258, 424-429.
51. Du,W. and Maniatis,T. (1994) The high mobility group protein HMG I (Y) can stimulate or inhibit DNA binding of distinct transcription factor ATF-2 isoforms. Proc. Natl Acad. Sci. USA, 91, 11318-11322.